Showing results (11-20 of 55) with videos related to
Sort By:
Pageof 6
The Journal of Biological Chemistry|October 8, 2003
A novel effect of bismuth ions: selective inhibition of the biological activity of glycine-extended gastrinJulie Pannequin, Suzana Kovac, John-Paul Tantiongco, et al.Journal of Protein Chemistry|January 14, 2003
Preparation of biologically active recombinant human progastrin(1-80)Kim McQueen, Suzana Kovac, Po-Ki Ho, et al.Cancer Cell International|February 16, 2016
Antibiotics inhibit sphere-forming ability in suspension cultureSébastien Relier, Laura Yazdani, Oualid Ayad, et al.The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
C-terminal heptapeptide of gastrin inhibits astrocytomas motility by interacting with a new gastrin binding siteJulie Pannequin, Catherine Oiry, Caroline Morel, et al.Gastroenterology|March 31, 2009
The symplekin/ZONAB complex inhibits intestinal cell differentiation by the repression of AML1/Runx1Michael Buchert, Charbel Darido, Ebba Lagerqvist, et al.Stem Cell Reports|March 11, 2015
The p53 isoform Δ133p53β promotes cancer stem cell potentialNikola Arsic, Gilles Gadea, E Louise Lagerqvist, et al.Journal of Cellular and Molecular Medicine|December 16, 2020
Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancerSabrina Blondy, Hugo Talbot, Sofiane Saada, et al.Nature Communications|January 25, 2014
SLAP displays tumour suppressor functions in colorectal cancer via destabilization of the SRC substrate EPHA2Cécile Naudin, Audrey Sirvent, Cédric Leroy, et al.British Journal of Cancer|September 20, 2024
Comparison of methods for cancer stem cell detection in prognosis of early stages NSCLCBoutaîna Chandouri, Thomas Naves, May Yassine, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Symplekin promotes tumorigenicity by up-regulating claudin-2 expressionMichael Buchert, Marina Papin, Caroline Bonnans, et al.Pageof 6